Tipo |
Título / Nombre |
Autor(es) |
Año |
|
Physician-perceived utility of the EORTC QLQ-GINET21 questionnaire in the treatment of patients with gastrointestinal neuroendocrine tumours: a multicentre, cross-sectional survey (QUALINETS) |
Benavent M, Sastre J, Escobar IG, Segura A, Capdevila J, Carmona A, Sevilla I, Alonso T, Crespo G, García L, Canal N, de la Cruz G, Gallego J |
2021 |
|
Influencia de la enfermedad tromboembólica venosa sobre la calidad de vida de pacientes oncológicos |
Oncala Sibajas E, Gálvez San Román JL, Muñoz Martín AJ, Font C, García-Escobar I, Jara Palomares L |
2018 |
|
Treatment and long-term clinical outcomes of incidental pulmonary embolism in cancer patients: an international prospective cohort study |
Kraaijpoel N, Bleker SM, van Es N, Mahé L, Muñoz A, Meyer G, Planquette B, Sánchez O, Bertoletti L, Accasat S, Magalhaes de E, Baars J, Rutten A, Lalezari F, Beyer-Westendorf J, Endig S, Marten S, Porreca E, Rutjes AW, Russi I, Constans J, Boulon C, Kleinjan A, Beenen LFM, Iosub D, Piovella F, Couturaud F, Tromeur C, Biosca M, Assaf JD, HelfermH, Pinson M, Lerede T, Falanga A, Lacroix P, Désormais I, Maraveyas A, Bozas G, Aggarwal A, Rickles F, Girard P, Caliandro R, Martínez del Prado P, Prado Maneiro de C, García Escobar I, González Santiago S, Schmidt J, Dublanchet N, Aquilanti S, Confrere E, Paleirón N, Grange C, Sevestre MA, Ferrer Pérez AI, Salgado Fernández M, Falvo N, Thaler J, Otten HM, Carrier M, Bergmann JF, Büller HR, Di Nisio M |
2018 |
|
Incidence, predictors and prognostic significance of thromboembolic disease in patients with advanced ALK-rearranged non-small cell lung cancer |
Zugazagoitia J, Biosca M, Oliveira J, Olmedo ME, Dómine M, Nadal E, Ruffinelli JC, Muñoz N, Luna AM, Hernández B, Martínez M, Gallego I, Martínez de Castro E, Font C, Calvo V, Martínez-Marín V, CorralJ, Noguerón E, Mondéjar R, García Escobar I, Salvador-Coloma C, Juan Ó, Sánchez Cánovas M, Valdivia J, Ochoa MP, López Castro R, Obispo B, Pangua C, Sereno M, Fernández Franco L, Mielgo X, Calzas J, Blasco A, Aparisi F, Chara L, Grau JF, Soares M, Gómez A, Zenzola V, García-Morillo M, Cacho D, Díaz-Serrano A, Aguado C, Ponce-Aix S, González-Larriba JL, Muñoz AJ, Lora D, Paz-Ares L, Manzano A |
2018 |
|
Massive Pulmonary Embolism in Oncological Patient with Cetuximab Treatment: Hipercoagulability Status in Cancer Patients - A Case Report and a Review of Scientific Literature |
Illan A, Aires J, Ayala P, Gorospe I, Muñoz J, Quintana L,
, Collado R, Rodríguez MA, Borrega P, López de Ceballos MH,
, González S, Alonso S, García-Escobar I |
2017 |
|
Safety and efficacy of primary thromboprophylaxis in cancer patients |
García Escobar I, Antonio Rebollo M, García Adrián S, Rodríguez-Garzotto A, Muñoz Martín A , Cancer&38, Thrombosis Working Group of the Spanish Society of Medical Oncology (SEOM) |
2017 |
|
Validación del modelo pronóstico del International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) para pazopanib en primera línea de cáncer renal avanzado: estudio SPAZO, del Grupo Español de Tumores Genitourinarios (SOGUG) |
Borrega García P, García Escobar I, Collado Martín R, Quintana Cortés L, Aires Machado J |
2016 |